Explore more publications!

Press Releases

Hume Band (2026 CONSUMER REPORT): Revolutionary "Metabolic Momentum Protocol" Redefines Personal Health Monitoring and Longevity
Bertrand P. Cole, D.O. - 723495 - 02/02/2026

Bertrand P. Cole, D.O. - 723495 - 02/02/2026

INVESTOR DEADLINE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law
ACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
Ardent Health, Inc. Investors with Significant Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit - Robbins Geller Rudman & Dowd LLP
Fortified Foods Market to Hit US$268.8B by 2033 at 7.4% CAGR on Rising Health Demand
Circadian Health and AlohaCare Offer New Heart Health Monitoring Services
Bertrand P. Cole, D.O./Activmed Practices and Research, LLC - 723495 - 02/02/2026

Bertrand P. Cole, D.O./Activmed Practices and Research, LLC - 723495 - 02/02/2026

Tenvie Therapeutics Appoints Don O’Sullivan, Ph.D., MBA, as Chief Business Officer
New Alliance Brings Together 1.2 Million Illinois Rare Disease Patients
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference
GlycoPezil Supplement Claims Evaluated - Complete Investigation of the Blood Sugar Support Ingredients
Zimmermann Modern Wellness Launches IV Wellness Program
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Jellies & Gummies Market Size Forecast to USD 13.0 Billion by 2036 with Rising Demand for Functional Nutrition – by TMR
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
Diligence Care Plus Encourages Healthier Relationships This Valentine’s Day

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions